[Experience in the use of streptodecase in the treatment of intraocular hemorrhage].
Addition of streptodecase to combined therapy of intraocular hemorrhages, mainly of vascular origin, in 37 patients improved the treatment efficacy. This manifested by a noticeable improvement of the vision acuity and by a more marked and complete resorption of the hemorrhages. The results were better if the drug was administered in the earliest periods of the disease. Local allergic reactions, seen in 27% of patients, were the most frequent side effect of streptodecase therapy.